Sinopharm Group Co Ltd
HKEX:1099
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sinopharm Group Co Ltd
HKEX:1099
|
CN |
|
Tango Therapeutics Inc
NASDAQ:TNGX
|
US |
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
US |
|
Synaptics Inc
NASDAQ:SYNA
|
US |
|
TechTarget Inc
NASDAQ:TTGT
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Cousins Properties Inc
NYSE:CUZ
|
US |
|
Agilent Technologies Inc
NYSE:A
|
US |
|
Ezenia! Inc
OTC:EZEN
|
US |
|
Extreme Networks Inc
NASDAQ:EXTR
|
US |
|
K
|
KeyMed Biosciences Inc
HKEX:2162
|
CN |
|
Iss A/S
CSE:ISS
|
DK |
|
A
|
Angel Oak Mortgage Inc
NYSE:AOMR
|
US |
|
Trade Desk Inc
NASDAQ:TTD
|
US |
|
CrowdFundMe SpA
MIL:CFM
|
IT |
|
Korn Ferry
NYSE:KFY
|
US |
|
Tetra Technologies Inc
NYSE:TTI
|
US |
|
Franchi Umberto Marmi SpA
MIL:FUM
|
IT |
|
Unisys Corp
NYSE:UIS
|
US |
|
I
|
IDNTT SA
MIL:IDNTT
|
CH |
|
Armstrong World Industries Inc
NYSE:AWI
|
US |
|
Repco Home Finance Ltd
NSE:REPCOHOME
|
IN |
|
Renova Inc
TSE:9519
|
JP |
|
Prysmian SpA
MIL:PRY
|
IT |
Wall St Price Targets
Price Targets Summary
Sinopharm Group Co Ltd
According to Wall Street analysts, the average 1-year price target for Sinopharm Group Co Ltd is 23.07 HKD with a low forecast of 17.17 HKD and a high forecast of 28.32 HKD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Sinopharm Group Co Ltd's stock price target?
Price Target
23.07
HKD
According to Wall Street analysts, the average 1-year price target for Sinopharm Group Co Ltd is 23.07 HKD with a low forecast of 17.17 HKD and a high forecast of 28.32 HKD.
What is the Revenue forecast for Sinopharm Group Co Ltd?
Projected CAGR
5%
Over the last 14 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 3 years is 5%.
What is the Operating Income forecast for Sinopharm Group Co Ltd?
Projected CAGR
26%
Over the last 14 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 3 years is 26%.
What is the Net Income forecast for Sinopharm Group Co Ltd?
Projected CAGR
9%
Over the last 14 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 3 years is 9%.
